Seroprevalence of xenotropic murine leukemia virus-related virus in normal and retrovirus-infected blood donors

Transfusion

Volumn 52, Issue 2, 2012, Pages 307-316

  Qiu, Xiaoxing ^a,b   Swanson, Priscilla ^a,b   Tang, Ning ^a,b   Leckie, Gregor W ^a,b   Devare, Sushil G ^a,b   Schochetman, Gerald ^a,b   Hackett Jr, John ^a,b  

^a ABBOTT DIAGNOSTICS   (United States)

^b Abbott Molecular Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CROSS REACTING ANTIBODY; ENVELOPE PROTEIN; EPITOPE; GLYCOPROTEIN GP 70; MEMBRANE PROTEIN; POL PROTEIN; PROTEIN P15E; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BLOOD DONOR; BLOOD SAFETY; BLOOD TRANSFUSION; CAMEROON; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENVELOPE GENE; GENETIC CONSERVATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOASSAY; JAPANESE; MAJOR CLINICAL STUDY; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; RETROVIRUS; RETROVIRUS INFECTION; SEQUENCE ANALYSIS; SEROPREVALENCE; SEXUALLY TRANSMITTED DISEASE; STRUCTURAL GENE; WESTERN BLOTTING; XENOTROPIC MULV RELATED VIRUS;

ANTIBODIES; BLOOD DONORS; BLOOD SAFETY; FATIGUE SYNDROME, CHRONIC; HEALTH; HUMANS; POPULATION; RETROVIRIDAE INFECTIONS; RETROVIRIDAE PROTEINS, ONCOGENIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, VIRAL; SEROEPIDEMIOLOGIC STUDIES; SEXUALLY TRANSMITTED DISEASES, VIRAL; VIRAL ENVELOPE PROTEINS; XENOTROPIC MURINE LEUKEMIA VIRUS-RELATED VIRUS;

EID: 84855846871     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03395.x     Document Type: Article

References (36)

1. Urisman A, Molinaro RJ, Fischer N, Plummer SJ, Casey G, Klein EA, Malathi K, Magi-Galluzzi C, Tubbs RR, Ganem D, Silverman RH, DeRisi JL,. Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog 2006; 2: e25.
2. Schlaberg R, Choe DJ, Brown KR, Thaker HM, Singh IR,. XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors. Proc Natl Acad Sci U S A 2009; 106: 16351-6.
3. Lombardi VC, Ruscetti FW, Das Gupta J, Pfost MA, Hagen KS, Peterson DL, Ruscetti SK, Bagni RK, Petrow-Sadowski C, Gold B, Dean M, Silverman RH, Mikovits JA,. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 2009; 326: 585-9.
4. Fischer N, Hellwinkel O, Schulz C, Chun FK, Huland H, Aepfelbacher M, Schlomm T,. Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer. J Clin Virol 2008; 43: 277-83.
5. Hohn O, Krause H, Barbarotto P, Niederstadt L, Beimforde N, Denner J, Miller K, Kurth R, Bannert N,. Lack of evidence for xenotropic murine leukemia virus-related virus (XMRV) in German prostate cancer patients. Retrovirology 2009; 6: 92.
6. Arnold RS, Makarova NV, Osunkoya AO, Suppiah S, Scott TA, Johnson NA, Bhosle SM, Liotta D, Hunter E, Marshall FF, Ly H, Molinaro RJ, Blackwell JL, Petros JA,. XMRV infection in patients with prostate cancer: novel serologic assay and correlation with PCR and FISH. Urology 2010; 75: 755-61.
7. Danielson BP, Ayala GE, Kimata JT,. Detection of xenotropic murine leukemia virus-related virus in normal and tumor tissue of patients from the southern United States with prostate cancer is dependent on specific polymerase chain reaction conditions. J Infect Dis 2010; 202: 1470-7.
8. Verhaegh GW, de Jong AS, Smit FP, Jannink SA, Melchers WJ, Schalken JA,. Prevalence of human xenotropic murine leukemia virus-related gammaretrovirus (XMRV) in Dutch prostate cancer patients. Prostate 2011; 71: 415-20.
9. Aloia AL, Sfanos KS, Isaacs WB, Zheng Q, Maldarelli F, De Marzo AM, Rein A,. XMRV, a new virus in prostate cancer? Cancer Res 2010; 70: 10028-33.
10. Sakuma T, Hue S, Squillace KA, Tonne JM, Blackburn PR, Ohmine S, Thatava T, Towers GJ, Ikeda Y,. No evidence of XMRV in prostate cancer cohorts in the midwestern United States. Retrovirology 2011; 8: 23.
11. Switzer WM, Jia H, Hohn O, Zheng H, Tang S, Shankar A, Bannert N, Simmons G, Hendry RM, Falkenberg VR, Reeves WC, Heneine W,. Absence of evidence of xenotropic murine leukemia virus-related virus infection in persons with chronic fatigue syndrome and healthy controls in the United States. Retrovirology 2010; 7: 57.
12. Erlwein O, Kaye S, McClure MO, Weber J, Wills G, Collier D, Wessely S, Cleare A,. Failure to detect the novel retrovirus XMRV in chronic fatigue syndrome. PLoS ONE 2010; 5: e8519.
13. Groom HC, Boucherit VC, Makinson K, Randal E, Baptista S, Hagan S, Gow JW, Mattes FM, Breuer J, Kerr JR, Stoye JP, Bishop KN,. Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome. Retrovirology 2010; 7: 10.
14. van Kuppeveld FJ, de Jong AS, Lanke KH, Verhaegh GW, Melchers WJ, Swanink CM, Bleijenberg G, Netea MG, Galama JM, van der Meer JW,. Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort. BMJ 2010; 340: c1018.
15. Hong P, Li J, Li Y,. Failure to detect xenotropic murine leukaemia virus-related virus in Chinese patients with chronic fatigue syndrome. Virol J 2010; 7: 224.
16. Hohn O, Strohschein K, Brandt AU, Seeher S, Klein S, Kurth R, Paul F, Meisel C, Scheibenbogen C, Bannert N,. No evidence for XMRV in German CFS and MS patients with fatigue despite the ability of the virus to infect human blood cells in vitro. PLoS ONE 2010; 5: e15632.
17. Furuta RA, Miyazawa T, Sugiyama T, Kuratsune H, Ikeda Y, Sato E, Misawa N, Nakatomi Y, Sakuma R, Yasui K, Yamaguti K, Hirayama F,. No association of xenotropic murine leukemia virus-related virus with prostate cancer or chronic fatigue syndrome in Japan. Retrovirology 2011; 8: 20.
18. Knox K, Carrigan D, Simmons G, Teque F, Zhou Y, Hackett J Jr, Qiu X, Luk KC, Schochetman G, Knox A, Kogelnik AM, Levy JA,. No evidence of murine-like gammaretroviruses in CFS patients previously identified as XMRV-infected. Science 2011; 333: 94-7.
19. Lo SC, Pripuzova N, Li B, Komaroff AL, Hung GC, Wang R, Alter HJ,. Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors. Proc Natl Acad Sci U S A 2010; 107: 15874-9.
20. Dong B, Kim S, Hong S, Das Gupta J, Malathi K, Klein EA, Ganem D, Derisi JL, Chow SA, Silverman RH,. An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proc Natl Acad Sci U S A 2007; 104: 1655-60. (Pubitemid 46214646)
21. Stieler K, Schulz C, Lavanya M, Aepfelbacher M, Stocking C, Fischer N,. Host range and cellular tropism of the human exogenous gammaretrovirus XMRV. Virology 2010; 399: 23-30.
22. Rodriguez JJ, Goff SP,. Xenotropic murine leukemia virus-related virus establishes an efficient spreading infection and exhibits enhanced transcriptional activity in prostate carcinoma cells. J Virol 2010; 84: 2556-62.
23. Onlamoon N, Gupta JD, Sharma P, Rogers K, Suppiah S, Rhea J, Molinaro R, Gaughan C, Dong B, Klein EA, Qiu X, Devare S, Schochetman G, Hackett J Jr, Silverman RH, Villinger F,. Infection, viral dissemination and immune responses of rhesus macaques exposed to the human gammaretrovirus XMRV. J Virol 2011; 85: 4547-57.
24. Sakuma T, Tonne JM, Squillace KA, Ohmine S, Thatava T, Peng KW, Barry MA, Ikeda Y,. Early events in retrovirus XMRV infection of the wild-derived mouse, Mus pahari. J Virol 2011; 85: 1205-13.
25. Qiu X, Swanson P, Luk KC, Tu B, Villinger F, Das Gupta J, Silverman RH, Klein EA, Devare S, Schochetman G, Hackett J Jr,. Characterization of antibodies elicited by XMRV infection and development of immunoassays useful for epidemiologic studies. Retrovirology 2010; 7: 68.
26. Simmons G, Glynn SA, Holmberg JA, Coffin JM, Hewlett IK, Lo SC, Mikovits JA, Switzer WM, Linnen JM,; Busch MP for the Blood XMRV Scientific Research Working Group. The blood xenotropic murine leukemia virus-related virus scientific research working group: mission, progress, and plans. Transfusion 2011; 51: 643-53.
27. Hong S, Klein EA, Das Gupta J, Hanke K, Weight CJ, Nguyen C, Gaughan C, Kim KA, Bannert N, Kirchhoff F, Munch J, Silverman RH,. Fibrils of prostatic acid phosphatase fragments boost infections with XMRV (xenotropic murine leukemia virus-related virus), a human retrovirus associated with prostate cancer. J Virol 2009; 83: 6995-7003.
28. Spindler J, Hackett J Jr, Qiu X, Wiegand A, Boltz VF, Swanson P, Bream JH, Jacobson LP, Li X, Rinaldo CR, Wolinsky SM, Coffin JM, Kearney MF, Mellors JW,. Prevalence of XMRV nucleic acid and antibody in HIV-1 infected men and in men at risk for HIV-1 infection. Adv Virol. In press.
29. Barnes E, Flanagan P, Brown A, Robinson N, Brown H, McClure M, Oxenius A, Collier J, Weber J, Günthard HF, Hirschel B, Fidler S, Phillips R, Frater J,. Failure to detect xenotropic murine leukemia virus-related virus in blood of individuals at high risk of blood-borne viral infections. J Infect Dis 2010; 202: 1482-5.
30. Kunstman KJ, Bhattacharya T, Flaherty J, Phair JP, Wolinsky SM,. Absence of xenotropic murine leukemia virus-related virus in blood cells of men at risk for and infected with HIV. AIDS 2010; 24: 1784-5.
31. Cornelissen M, Zorgdrager F, Blom P, Jurriaans S, Repping S, van Leeuwen E, Bakker M, Berkhout B, van der Kuyl AC,. Lack of detection of XMRV in seminal plasma from HIV-1 infected men in The Netherlands. PLoS ONE 2010; 5: e12040.
32. Tang S, Zhao J, Viswanath R, Nyambi PN, Redd AD, Dastyar A, Spacek LA, Quinn TC, Wang X, Wood O, Gaddam D, Devadas K, Hewlett IK,. Absence of detectable xenotropic murine leukemia virus-related virus in plasma or peripheral blood mononuclear cells of human immunodeficiency virus type one infected blood donors or individuals in Africa. Transfusion 2011; 51: 463-8.
33. Gray ER, Garson JA, Breuer J, Edwards S, Kellam P, Pillay D, Towers GJ,. No evidence of XMRV or related retroviruses in a London HIV-1-positive patient cohort. PLoS ONE 2011; 6: e18096.
34. Paprotka T, Delviks-Frankenberry KA, Cingöz O, Martinez A, Kung HJ, Tepper CG, Hu WS, Fivash MJ Jr, Coffin JM, Pathak VK,. Recombinant origin of the retrovirus XMRV. Science 2011; 333: 97-101.
35. Smith RA,. Contamination of clinical specimens with MLV-encoding nucleic acids: implications for XMRV and other candidate human retroviruses. Retrovirology 2010; 7: 112.
36. Garson JA, Kellam P, Towers GJ,. Analysis of XMRV integration sites from human prostate cancer tissues suggests PCR contamination rather than genuine human infection. Retrovirology 2011; 8: 13.